netupitant 300 MG / palonosetron 0.5 MG Oral Capsule [Akynzeo]
RxNorm concept 1552349, branded drug (sbd). Prescribable name: Akynzeo 300 MG / 0.5 MG Oral Capsule.
- RxCUI
- 1552349
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1552349 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Akynzeo (netupitant 300 MG / palonosetron 0.5 MG (palonosetron hydrochloride 0.56 MG)) Oral Capsule; Akynzeo (netupitant 300 MG / palonosetron 0.5) MG Oral Capsule
Related concepts
- palonosetron 0.5 MG (SCDC, consists of)
- netupitant 300 MG (SCDC, consists of)
- netupitant 300 MG / palonosetron 0.5 MG [Akynzeo] (SBDC, consists of)
- Oral Capsule (DF, has dose form)
- Akynzeo (BN, has ingredient)
- netupitant 300 MG / palonosetron 0.5 MG Oral Capsule (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1552349 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1552349 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1552349. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.